AFYREN (90N) AI Stock Analysis

AFYREN

(Frankfurt:90N)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low financial leverageThe substantial reduction in debt and low leverage provide AFYREN with greater financial flexibility than a highly indebted industrial business. This can reduce refinancing pressure, preserve capacity to fund operations, and give management more room to pursue commercialization while losses remain elevated.

Negative Factors

Sustained revenue contractionRepeated revenue declines indicate that commercial scale-up and customer offtake are not yet producing durable top-line expansion. Continued contraction can weaken operating leverage, delay efficient plant utilization, and make it harder for AFYREN to absorb fixed costs or establish a self-sustaining growth trajectory.

AFYREN (90N) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 87.81M
Dividend Yield: ―
Average Volume (3M): 1,426
Price to Earnings (P/E): -11.4
Beta (1Y): 0.04
Revenue Growth: -13.62%
EPS Growth: 54.46%
Country: Germany
Employees: 149
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals - Specialty

AFYREN Business Overview & Revenue Model

Company Description

AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubric...

AFYREN Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:90N against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:AI	73Outperform	EUR 115.22B	30.98	13.42%	1.69%	-1.30%	3.05%
FR:CBE	63Neutral	EUR 1.57B	16.03	―	1.92%	0.30%	0.78%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
FR:AKE	56Neutral	EUR 4.30B	329.70	0.92%	6.42%	-5.73%	-73.67%
FR:ALBKK	55Neutral	EUR 74.86M	45.33	3.51%	1.47%	6.97%	-73.50%
FR:ALCRB	46Neutral	EUR 87.05M	-4.33	-10.62%	―	―	―

* Basic Materials Sector Average

Performance Comparison

DE:90N and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:90N	AFYREN	2.23	0.08	3.95%
FR:AI	Air Liquide (UK)	180.90	31.59	21.16%
FR:AKE	Arkema SA (UK)	56.05	8.76	18.51%
FR:ALCRB	Carbios SA	5.15	-1.96	-27.62%
FR:ALBKK	Baikowski SA	20.40	-2.32	-10.23%
FR:CBE	Robertet SA Cert.d'Invest. Em.87	625.00	-82.39	-11.65%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

AFYREN AI Stock Analysis